190 related articles for article (PubMed ID: 7481353)
1. [Inefficacy of oral antidiabetics: failure or natural history of diabetes?].
Schönenweid C
Rev Med Suisse Romande; 1995 Sep; 115(9):671-3. PubMed ID: 7481353
[No Abstract] [Full Text] [Related]
2. [Delayed action of oral antidiabetic treatments. Place of combination of insulin and hypoglycemic sulfamides].
Leutenegger M; Nakib Y; Grulet H; Gross A; Boirie Y
Journ Annu Diabetol Hotel Dieu; 1993; ():97-114. PubMed ID: 8331877
[No Abstract] [Full Text] [Related]
3. [Renewal of oral therapy for diabetes mellitus after secondary failure].
Guberman D
Harefuah; 1989 Nov; 117(9):240-1. PubMed ID: 2693275
[TBL] [Abstract][Full Text] [Related]
4. Refill compliance in type 2 diabetes mellitus: a predictor of switching to insulin therapy?
Spoelstra JA; Stolk RP; Heerdink ER; Klungel OH; Erkens JA; Leufkens HG; Grobbee DE
Pharmacoepidemiol Drug Saf; 2003 Mar; 12(2):121-7. PubMed ID: 12642975
[TBL] [Abstract][Full Text] [Related]
5. A comparative study of insulin lispro and human regular insulin in patients with type 2 diabetes mellitus and secondary failure of oral hypoglycemic agents.
Ross SA; Zinman B; Campos RV; Strack T;
Clin Invest Med; 2001 Dec; 24(6):292-8. PubMed ID: 11767232
[TBL] [Abstract][Full Text] [Related]
6. Inhaled human [rDNA origin] insulin, a novel formulation for diabetes mellitus.
Pham DQ; Cohen H; Chu V
J Clin Pharmacol; 2007 Jul; 47(7):890-903. PubMed ID: 17585117
[TBL] [Abstract][Full Text] [Related]
7. [Escaping oral hypoglycemic agents in type 2 diabetes: importance and limitations of transitory optimized insulin therapy].
Leutenegger M; Bertin E; Grulet H
Diabetes Metab; 1998 Feb; 24(1):80-4. PubMed ID: 9534015
[No Abstract] [Full Text] [Related]
8. [Approach to diabetes therapy. 2. Selection and the use of oral antidiabetics. 2) Agents to correct insulin resistance].
Kashiwagi A; Maegawa H
Nihon Naika Gakkai Zasshi; 2000 Aug; 89(8):1530-5. PubMed ID: 11062900
[No Abstract] [Full Text] [Related]
9. [What is new in the treatment of diabetes mellitus?].
Gain T
Krankenpfl J; 2000 Oct; 38(9-10):328-31. PubMed ID: 11194350
[No Abstract] [Full Text] [Related]
10. Type II diabetes: insulin versus oral agents.
Martin DB
N Engl J Med; 1986 May; 314(20):1314-5. PubMed ID: 3517646
[No Abstract] [Full Text] [Related]
11. Pharmaceutical intervention in diabetes management.
Draheim MD
Gastroenterol Nurs; 1995; 18(5):190-5. PubMed ID: 7578302
[TBL] [Abstract][Full Text] [Related]
12. [Optimal therapeutic strategy in type 2 diabetes mellitus].
Scherbaum WA; Nitschmann S
Internist (Berl); 2009 Feb; 50(2):244-8. PubMed ID: 19183919
[No Abstract] [Full Text] [Related]
13. [Oral treatment of diabetes mellitus type 2. Limitations, perspectives].
Dumitrescu C; Găvănescu M
Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna; 1986; 38(1):71-7. PubMed ID: 2873647
[No Abstract] [Full Text] [Related]
14. [Therapy with oral antidiabetics 1983].
Berchtold P; Berger M
Ther Umsch; 1983 Oct; 40(10):883-90. PubMed ID: 6359559
[No Abstract] [Full Text] [Related]
15. Exploring treatment strategies for type 2 diabetes.
Bloomgarden ZT
Diabetes Care; 2007 Oct; 30(10):2737-45. PubMed ID: 17901531
[No Abstract] [Full Text] [Related]
16. Treatment of type 2 diabetes with combined therapy: what are the pros and cons?
Massi-Benedetti M; Orsini-Federici M
Diabetes Care; 2008 Feb; 31 Suppl 2():S131-5. PubMed ID: 18227473
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of combination therapy with insulin and oral hypoglycemic agents in patients with type II diabetes during a 1-year period.
Mozersky RP; Patel H; Bahl VK; Bahl S; Mook W
J Am Osteopath Assoc; 1996 Jun; 96(6):346-51. PubMed ID: 8690621
[TBL] [Abstract][Full Text] [Related]
18. Pathophysiology and treatment of patients with type 2 diabetes exhibiting failure to oral drugs.
Efendic S; Alvarsson M; Brismar K; Wagner H
Acta Physiol (Oxf); 2008 Jan; 192(1):117-25. PubMed ID: 18171434
[TBL] [Abstract][Full Text] [Related]
19. Improved glycaemic control with BIAsp 30 in insulin-naïve type 2 diabetes patients inadequately controlled on oral antidiabetics: subgroup analysis from the IMPROVE study.
Wenying Y; Benroubi M; Borzi V; Gumprecht J; Kawamori R; Shaban J; Shah S; Shestakova M; Ligthelm R; Valensi P;
Curr Med Res Opin; 2009 Nov; 25(11):2643-54. PubMed ID: 19751116
[TBL] [Abstract][Full Text] [Related]
20. What to do when two oral agents fail to control type 2 diabetes--a matter of opinion or a matter of fact?
Ahmann AJ; Riddle MC
Am J Med; 2004 Feb; 116(4):276-8. PubMed ID: 14969657
[No Abstract] [Full Text] [Related]
[Next] [New Search]
